PEGylation involves the covalent attachment of PEG molecules to nanoparticles or therapeutic agents. This is typically achieved through chemical reactions that link the hydroxyl groups of PEG to functional groups on the target molecule. The PEG chains create a hydrophilic "shield" around the nanoparticle, which can reduce immunogenicity and prevent protein binding.
